Showing 4 results for Hypertension
Elahe Seddighi Looye, Lida Moghaddam Banaem, Azam Afshar,
Volume 17, Issue 4 (2-2012)
Abstract
Background & Aim: This study aimed to assess the relationships between iron and copper levels in maternal and cord serums together and with pregnancy outcomes.
Methods & Materials: An Analytical cross-sectional study was conducted among 370 pregnant women in labor and their neonates in Maryam, Akbarabadi and Imam hospitals in Tehran, Iran. Copper concentrations were measured using the standard atomic absorption spectrophotometer method and Iron concentrations were measured by a kit through RA 1000 method. Data were collected using a questionnaire and were analyzed using Spearman correlation, Chi- square and Logistic regression tests.
Results: The mean copper concentrations in the maternal and cord bloods at delivery were 114.52±37.4, 22.4±11.6 (μg/dl), respectively. The Iron levels were 119.2±64, 164.3±65.3 (μg/dl), respectively. Of all the mothers, 54.3% had copper deficiency, 1.1% Iron deficiency and of all the newborns, 44.7% had copper deficiency and 3.5% Iron deficiency. The Spearman Correlation analysis showed significant positive correlations between concentrations of each element in maternal serum with cord serum and also between maternal iron with maternal copper, and maternal iron with cord copper. The Chi-square analysis showed that there was a significant relationship between maternal copper deficiency and gestational hypertension (P<0.001). There were no significant relationships between these trace element levels at delivery with premature rupture of membranes and preterm labor. Logistic regression analysis showed a significant negative relationship between maternal copper levels and gestational hypertension (odds: 0.98, 95%CI: 0.97-0.99).
Conclusion: Maternal copper deficiency was rather high in the participants of the study (54.3%), and was related to incidence of gestational hypertension. These findings illustrated importance of trace elements during pregnancy. Providing suitable dietary recommendations and giving supplements during pregnancy can help to decrease maternal and fetal mortality and morbidity.
Samira Khatar, Leila Mirhadyan, Homa Mosaffa Khomami, Ehsan Kazemnejad Leili,
Volume 29, Issue 1 (4-2023)
Abstract
Background & Aim: Many factors affect the hypertensive patients’ quality of life. Identifying the factors related to the quality of life can help to promote the quality of life in hypertensive patients. This study aimed to determine the predictive role of illness acceptance and social, individual factors in the hypertensive patients’ quality of life.
Methods & Materials: This correlational, cross-section study was conducted in 2020-2021 on 245 hypertensive patients referred to a hypertension clinic in Lahijan selected by the convenience sampling method. Data were collected by a questionnaire, including demographic information, Acceptance of Illness Scale and the WHO's Quality of Life-Brief questionnaire. Data were analyzed by multiple linear regression at a 95% confidence level using the SPSS software version 23.
Results: The mean score for the quality of life was 65.32±12.18 (0-100) and for the acceptance of illness was 31.83±4.98 (8-40). Age, sex, employment status, marital status, monthly income, family arrangement and the acceptance of illness were identified as the predictors of quality of life in hypertensive patients (P<0.001). According to the coefficient of determination (R2=0.401), the variables of the final regression model explained about 40% of the quality-of-life changes among hypertensive patients.
Conclusion: Given that the acceptance of illness and some social, individual factors can affect the hypertensive patients’ quality of life, focus on the strategies to promote the acceptance of illness and paying attention to social, individual factors can help improve the quality of life among hypertensive patients.
Zahra Ghaderi Nasab, Parvin Mangolian Shahrbabaki, Hamid Sharifi,
Volume 30, Issue 2 (6-2024)
Abstract
Background & Aim: Medication non-adherence remains a significant problem in managing the global epidemic of hypertension. This study aimed to explore the factors affecting medication non-adherence from the perspectives of both patients with hypertension and healthcare providers in Mahan health centers, located in Kerman province.
Methods & Materials: This qualitative study utilized a conventional content analysis method within healthcare centers in Mahan city in 2022. A total of 29 participants were included in the study, selected through purposive sampling. Data were collected through in-depth semi-structured interviews, with all interviews being recorded, transcribed verbatim, and utilized as the primary data for analysis. The trustworthiness of data was evaluated in accordance with the criteria established by Guba and Lincoln criteria.
Results: Three categories of factors contributing to medication non-adherence among patients with hypertension were identified: ""nature of the disease and treatment," "individual and family factors," and "organizational factors." Factors related to the "nature of the disease and treatment" included the asymptomatic and chronic nature of hypertension as well as fatigue stemming from continuous drug use. "Individual and family factors" encompassed fear and internal doubts, a desire for non-pharmacological treatments, and inadequate family support. "Organizational factors" comprised high treatment costs and access to specialized services, insufficient support from treatment and care teams, and inadequate disease monitoring.
Conclusion: Various factors across a spectrum of influences contribute to medication non-adherence in patients with hypertension. It is crucial for healthcare providers to engage in consistent patient education regarding the nature of the condition and the importance of medication adherence to enhance compliance among patients.
Amir Musarezaie, Mohammad Javad Tarrahi, Masoumeh Sadeghi, Sedigheh Farzi, Tahere Momeni-Ghale Ghasemi, Amir Hossein Saeidi, Maryam Sadat Shahshahani,
Volume 30, Issue 3 (9-2024)
Abstract
Background & Aim: The evidence shows that prehypertension is related to an increased risk of cardiovascular complications. This study aims to determine the effect of lavender inhalation aromatherapy on systolic and diastolic blood pressure (SBP & DBP) in people with prehypertension in Isfahan.
Methods & Materials: This two-group quasi-experimental study was conducted in 2023, involving 70 prehypertensive patients selected from comprehensive health service centers in Isfahan. Participants were selected through convenience sampling and were randomly assigned to either the experimental or control group. The intervention included inhalation aromatherapy using two drops of 100% pure lavender essential oil for 20 minutes in a single session. Blood pressure measurements were taken before, immediately after, and 10 and 20 minutes post-intervention under standardized conditions. The control group received routine health center training. Data analysis was performed using SPSS software version 26, employing descriptive and inferential statistics, including repeated measures analysis of variance (RMA) and analysis of covariance (ANCOVA), with a significance level set at 0.05.
Results: The results of the RMA indicated a significant interaction between time and group for both SBP (P<0.001) and DBP (P<0.001). Also, the intergroup effect for SBP was significant (P<0.001), demonstrating that the intervention group experienced a significantly greater reduction in average SBP compared to the control group. Intra-group analysis revealed a significant decrease in SBP before and after aromatherapy in the intervention group (P<0.001). In contrast, the control group did not show a significant change (P=0.068). Unlike SBP, the intergroup analysis for DBP did not yield significant results (P=0.141).
Conclusion: Considering the rising trend of high blood pressure and its widespread complications, along with the positive effects of aromatherapy as a cost-effective and accessible intervention, lavender inhalation aromatherapy is recommended as a complementary treatment strategy in conjunction with other methods.
